146 related articles for article (PubMed ID: 23848030)
21. Changing relationships of obesity and dyslipidemia in Greek children: 1982-2002.
Manios Y; Magkos F; Christakis G; Kafatos AG
Prev Med; 2005; 41(5-6):846-51. PubMed ID: 16256184
[TBL] [Abstract][Full Text] [Related]
22. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.
Mohammadi A; Sahebkar A; Iranshahi M; Amini M; Khojasteh R; Ghayour-Mobarhan M; Ferns GA
Phytother Res; 2013 Mar; 27(3):374-9. PubMed ID: 22610853
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
[TBL] [Abstract][Full Text] [Related]
24. Effect of Hibiscus sabdariffa Calices on Dyslipidemia in Obese Adolescents: A Triple-masked Randomized Controlled Trial.
Sabzghabaee AM; Ataei E; Kelishadi R; Ghannadi A; Soltani R; Badri S; Shirani S
Mater Sociomed; 2013; 25(2):76-9. PubMed ID: 24082826
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
26. The relationship between payer type and lipid outcomes in response to clinical lifestyle interventions in youth with dyslipidemia.
Hartz JC; Yellen E; Baker A; Zachariah J; Ryan H; Griggs SS; K Desai N; Yanumula R; Vinci S; Brantley C; Bachman J; McAuliffe E; Gauvreau K; Mendelson M; de Ferranti S
BMC Pediatr; 2019 Jul; 19(1):217. PubMed ID: 31266458
[TBL] [Abstract][Full Text] [Related]
27. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.
Ansari MR; Maheshwari N; Shaikh MA; Laghari MS; ; Lal K; Ahmed K
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):21-5. PubMed ID: 22237213
[TBL] [Abstract][Full Text] [Related]
28. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
[TBL] [Abstract][Full Text] [Related]
29. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Dyslipidemia and Associated Factors in Obese Children and Adolescents.
Elmaoğulları S; Tepe D; Uçaktürk SA; Karaca Kara F; Demirel F
J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):228-34. PubMed ID: 26831558
[TBL] [Abstract][Full Text] [Related]
31. Isolated low HDL cholesterol emerges as the most common lipid abnormality among obese adolescents.
Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
Clin Pediatr (Phila); 2010 Jan; 49(1):29-34. PubMed ID: 19628760
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
[TBL] [Abstract][Full Text] [Related]
33. The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial.
Safavi M; Farajian S; Kelishadi R; Mirlohi M; Hashemipour M
Int J Food Sci Nutr; 2013 Sep; 64(6):687-93. PubMed ID: 23477506
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of a new extended-release formulation of nicotinic acid in Korean adults with mixed dyslipidemia: an 8-week, multicenter, prospective, randomized, double-blind, and placebo-controlled trial.
Kim SH; Kim MK; Lee HY; Kang HJ; Kim YJ; Park BJ; Kim HS
Clin Ther; 2011 Oct; 33(10):1357-64. PubMed ID: 21955937
[TBL] [Abstract][Full Text] [Related]
35. [Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Li J; Zhang Y; Wang J; Feng P; Chen R; Cao Y; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):403-7. PubMed ID: 24754980
[TBL] [Abstract][Full Text] [Related]
36. [Body fat distribution: its characteristics and relationship to cardiovascular risk factors in obese Chinese].
Ran XW; Li XS; Tong NW; Li QF; Tang BD; Li XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):699-703. PubMed ID: 15460424
[TBL] [Abstract][Full Text] [Related]
37. Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia.
Maki KC; Lawless AL; Reeves MS; Kelley KM; Dicklin MR; Jenks BH; Shneyvas E; Brooks JR
Nutrition; 2013 Jan; 29(1):96-100. PubMed ID: 22796122
[TBL] [Abstract][Full Text] [Related]
38. Effect of a family-based cognitive behavioural intervention on body mass index, self-esteem and symptoms of depression in children with obesity (aged 7-13): a randomised waiting list controlled trial.
Danielsen YS; Nordhus IH; Júlíusson PB; Mæhle M; Pallesen S
Obes Res Clin Pract; 2013; 7(2):e116-e128. PubMed ID: 24331773
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children.
Casavalle PL; Lifshitz F; Romano LS; Pandolfo M; Caamaño A; Boyer PM; Rodríguez PN; Friedman SM
Pediatr Endocrinol Rev; 2014 Dec; 12(2):213-23. PubMed ID: 25581987
[TBL] [Abstract][Full Text] [Related]
40. Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents.
Posadas-Sánchez R; Posadas-Romero C; Zamora-González J; Mendoza-Pérez E; Cardoso-Saldaña G; Yamamoto-Kimura L
Metabolism; 2007 Dec; 56(12):1666-72. PubMed ID: 17998019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
